Etocube 120mg Tablet

Short Description

Etocube 120mg Tablet is a pain-relieving medicine used for relieving moderate pain and swelling of joints associated with different forms of gout and arthritis.

Dosage Form

Tablet

Introduction

Etocube 120mg Tablet is a non-steroidal anti-inflammatory drug (NSAID) that effectively alleviates pain, redness, and swelling associated with various forms of gout and arthritis. It works by blocking the release of certain chemical messengers responsible for pain and inflammation. While it may cause fewer stomach problems compared to other NSAIDs like Ibuprofen or Naproxen, it can still cause dizziness and fatigue. Patients are advised not to drive or engage in activities requiring concentration until they know how the medicine affects them. Regular monitoring of blood pressure is recommended, especially during the first two weeks of treatment. Patients with a history of stomach ulcers, heart diseases, high blood pressure, liver, or kidney disease should inform their doctor. Long-term treatment may require regular blood tests to monitor liver function. It is not recommended for use during pregnancy, planning to conceive, or breastfeeding.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Etocube 120mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Etocube 120mg Tablet is a non-steroidal anti-inflammatory drug (NSAID) called COX-2 inhibitors. It works by blocking the release of certain chemical messengers that are responsible for pain and inflammation (redness and swelling).

Etocube 120mg Tablet helps relieve pain and inflammation. May cause fewer stomach problems compared to other NSAIDs like Ibuprofen or Naproxen. May cause dizziness and fatigue. Do not drive or do anything requiring concentration until you know how it affects you. Do not consume alcohol while on treatment with this medicine as it may cause excessive drowsiness. Regularly monitor your blood pressure while taking this medicine, particularly in the first two weeks after starting treatment.